Ameritas Investment Partners
CGON icon

Ameritas Investment Partners’s CG Oncology CGON Stock Holding History

Ameritas Investment Partners’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Buy
6,698
+1,858
+38% +$121K 0.01% 924
2026
Q1 		$328K Buy
4,840
+172
+4% +$9.7K 0.01% 999
2025
Q4 		$194K Hold
4,668
– – 0.01% 1268
2025
Q3 		$188K Sell
4,668
-807
-15% -$23.5K 0.01% 1278
2025
Q2 		$142K Hold
5,475
– – ﹤0.01% 1502
2025
Q1 		$134K Buy
5,475
+670
+14% +$18.8K ﹤0.01% 1510
2024
Q4 		$138K Hold
4,805
– – ﹤0.01% 1565
2024
Q3 		$181K Buy
4,805
+2,485
+107% +$87.1K 0.01% 1385
2024
Q2 		$73.2K Hold
2,320
– – ﹤0.01% 1928
2024
Q1 		$102K Buy
+2,320
New +$94.8K ﹤0.01% 1724

Other funds holding CGON

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Decheng Capital
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameritas Investment Partners's CGON Position: Q2 2026 in Review

Ameritas Investment Partners increased its CG Oncology (CGON) stake by 38% in Q2 2026, buying an estimated $121K and bringing the position to 6,698 shares worth $476K. The position accounts for 0.01% of the portfolio, ranked #924.

Ameritas Investment Partners first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Ameritas Investment Partners held 6,698 shares of CG Oncology worth $476K as of Q2 2026.
  • Ameritas Investment Partners bought 1,858 CG Oncology shares in Q2 2026, an estimated $121K.
  • CG Oncology made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #924 holding.
  • Ameritas Investment Partners first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.